MannKind | Profitto Lordo Sulle Vendite

Gross Profit On Sales Cambiamento Data
Adma Biologics USD 31.09M 6.43M 2023-12
Dynavax Technologies USD 46.91M 9.38M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Insmed USD 65.25M 2.88M 2023-12
MannKind USD 40.4M 3.41M 2023-12
Novo Nordisk DKK 49.02B 2.57B 2023-09
Pfizer USD 7.58B 3.26B 2023-12



MannKind Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.